Kim Dennis D
Officer at CymaBay Therapeutics, Inc.; Chief Medical Officer at LRMR
- Sold, on record
- $2.7M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Apr 17, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- CymaBay Therapeutics, Inc.Officer
- LRMRLarimar Therapeutics, Inc.Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- CymaBay Therapeutics, Inc.120,100 shares
- LRMR40,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale LRMRUnusualSep 14, 2015 2015
Sold 593 shares at $40.00 ($24k)
Kim Dennis D, Chief Medical Officer
Sold 100% of holdings ($24k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale LRMRUnusualSep 17, 2015 +3 days
Sold 39,407 shares at $40.00 ($1.6M)
Kim Dennis D, Chief Medical Officer
Sold 100% of holdings ($1.6M position)0 shares leftFiling
- 3 Form 4 sale CymaBay Therapeutics, Inc.No planMar 28, 2023 +2749 days
Sold 100 shares at $8.99 ($899)
Kim Dennis D, Chief Medical Officer
No 10b5-1 planSold 0.5% of holdings ($181k position)20,000 shares leftFirst sale on recordFiling
- 4 Form 4 sale CymaBay Therapeutics, Inc.UnusualApr 17, 2023 +20 days
Sold 120,000 shares at $9.50 ($1.1M)
Kim Dennis D, Chief Medical Officer
No 10b5-1 planSold 85.7% of holdings ($1.3M position)20,000 shares leftFiling
- 5 Form 144 notice CymaBay Therapeutics, Inc.NoticeJun 30, 2023 +74 days
Filed to sell 139,344 shares ($1.5M)
Kim Dennis D, Officer
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2023 | Jun 30, 2023 | CymaBay Therapeutics, Inc. | Officer | Form 144 notice | 139,344 | $1.5M | Notice | SEC | |
| Apr 17, 2023 | Apr 17, 2023 | CymaBay Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 120,000 | $1.1M | 85.7% | Unusual | SEC |
| Mar 28, 2023 | Mar 30, 2023 | CymaBay Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 100 | $899 | 0.5% | No plan | SEC |
| Sep 17, 2015 | Sep 17, 2015 | LRMR | Chief Medical Officer | Form 4 sale | 39,407 | $1.6M | 100.0% | Unusual | SEC |
| Sep 14, 2015 | Sep 16, 2015 | LRMR | Chief Medical Officer | Form 4 sale | 593 | $24k | 100.0% | Unusual | SEC |